| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Xu Wang | |
| Ting Zhang | |||
| Wen-Zhe Ho | |||
| P2860 | cites work | CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 |
| Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 | ||
| Role of microglia in central nervous system infections | Q24563024 | ||
| Morphine Withdrawal Enhances Hepatitis C Virus Replicon Expression | Q27477516 | ||
| Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression | Q27478396 | ||
| Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes | Q27488883 | ||
| Upregulation of SOCS-3 and PIAS-3 Impairs IL-12-Mediated Interferon-Gamma Response in CD56+ T Cells in HCV-Infected Heroin Users | Q27491026 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
| Hepatitis C in the HIV-Infected Person | Q28206126 | ||
| Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 | ||
| Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons | Q28274676 | ||
| Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures | Q28330757 | ||
| Morphine stimulates HIV replication in primary cultures of human Kupffer cells | Q28333195 | ||
| Methadone enhances human immunodeficiency virus infection of human immune cells | Q28344125 | ||
| Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus | Q28367786 | ||
| Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcription | Q28474433 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Investigating the influence of treatment philosophy on outcome of methadone maintenance. | Q30417515 | ||
| Emerging evidence of hepatitis C virus neuroinvasion | Q31013540 | ||
| Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients | Q33346244 | ||
| Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. | Q33492170 | ||
| Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes | Q33593875 | ||
| Morphine Enhances HIV Infection of Neonatal Macrophages | Q33669599 | ||
| Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor | Q33683180 | ||
| Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis | Q33801352 | ||
| Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies | Q33819160 | ||
| Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner | Q33905849 | ||
| Effects of HCV treatment on cytokine expression during HCV/HIV coinfection | Q33961483 | ||
| High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives | Q33993892 | ||
| Detection and function of opioid receptors on cells from the immune system | Q33998561 | ||
| Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up | Q34061372 | ||
| The impact of hepatitis C virus infection on methadone maintenance treatment. | Q34077006 | ||
| Opioids, opioid receptors, and the immune response | Q34179298 | ||
| The liver as an immune organ | Q34261853 | ||
| Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. | Q34453357 | ||
| HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB | Q34509401 | ||
| Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine | Q34569281 | ||
| HIV infection and the gastrointestinal immune system | Q34601874 | ||
| The mucosal barrier and immune activation in HIV pathogenesis | Q34606638 | ||
| Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review | Q34637206 | ||
| Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes | Q34695803 | ||
| HIV infection increases HCV-induced hepatocyte apoptosis | Q34699457 | ||
| Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes | Q34756351 | ||
| Death receptor-mediated apoptosis and the liver | Q34783540 | ||
| HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines | Q34797566 | ||
| Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment | Q34893342 | ||
| Microbial Infections, Immunomodulation, and Drugs of Abuse | Q34926928 | ||
| Opioids, immunology, and host defenses of intravenous drug abusers | Q34950453 | ||
| Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection | Q35073676 | ||
| Immunoregulatory effects of morphine on human lymphocytes | Q35229000 | ||
| Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells | Q35578985 | ||
| Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients | Q35595809 | ||
| Heroin-Induces Differential Protein Expression by Normal Human Astrocytes (NHA). | Q35599877 | ||
| An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P. | Q35607410 | ||
| Viral hepatitis C. | Q35617324 | ||
| Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia | Q35677224 | ||
| Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. | Q35779664 | ||
| Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? | Q35866175 | ||
| Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. | Q36071315 | ||
| Opioids and the progression of simian AIDS. | Q36071748 | ||
| Methadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use. | Q36099168 | ||
| Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications | Q36235474 | ||
| The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. | Q36249104 | ||
| HIV disease: fallout from a mucosal catastrophe? | Q36398125 | ||
| The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy | Q36400457 | ||
| Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells | Q40692753 | ||
| Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor | Q40702376 | ||
| Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry | Q40722078 | ||
| Methadone induces CCR5 and promotes AIDS virus infection | Q40730523 | ||
| Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection | Q40778881 | ||
| Consequences of opiate-dependency in a monkey model of AIDS. | Q40778898 | ||
| The medical status of methadone maintenance patients in treatment for 11-18 years | Q40791224 | ||
| Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes | Q40869414 | ||
| Tuberculosis in drug users | Q40962666 | ||
| Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients | Q41326260 | ||
| SIV mutations detected in morphine-treated Macaca mulatta following SIVmac239 infection | Q41398130 | ||
| Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate | Q41526207 | ||
| Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. | Q41710040 | ||
| Lethality of morphine in mice infected with Toxoplasma gondii. | Q41815651 | ||
| Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways | Q42169348 | ||
| Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy | Q42602410 | ||
| Irish injecting drug users and hepatitis C: the importance of the social context of injecting. | Q42639237 | ||
| Hepatitis C in methadone maintenance patients: prevalence and public policy implications | Q42646672 | ||
| Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme. | Q42676897 | ||
| Prevalence and incidence of hepatitis C virus infection among young adult injection drug users | Q42680870 | ||
| Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs | Q42977231 | ||
| A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance | Q42986145 | ||
| Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters | Q42988172 | ||
| Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. | Q42989119 | ||
| Unscrambling hepatitis C virus-host interactions | Q42994469 | ||
| Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 | ||
| Hepatitis C Virus Infection and Progression of Infection Due to Human Immunodeficiency Virus | Q43038628 | ||
| Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication | Q43039725 | ||
| Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects | Q43040457 | ||
| Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus | Q43042290 | ||
| A study of susceptibility of primary human Kupffer cells to hepatitis C virus | Q43042430 | ||
| High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. | Q43047625 | ||
| Opiates as potential cofactors in progression of HIV-1 infections to AIDS. | Q43070988 | ||
| Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action | Q43071003 | ||
| Opiates and infection | Q43071007 | ||
| CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates | Q43123425 | ||
| Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice | Q43743324 | ||
| The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. | Q43982576 | ||
| Abrupt or precipitated withdrawal from morphine induces immunosuppression | Q44014891 | ||
| Effect of Morphine on Resistance to Infection | Q44014937 | ||
| Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme | Q44042748 | ||
| Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism | Q44131663 | ||
| Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection | Q44340791 | ||
| Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. | Q44341702 | ||
| Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization | Q44342822 | ||
| Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity | Q44347886 | ||
| Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial | Q44351590 | ||
| Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor | Q44351901 | ||
| Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients | Q44406911 | ||
| Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity | Q44520992 | ||
| Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules | Q44641628 | ||
| Morphine induces sepsis in mice | Q44644417 | ||
| Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures | Q44740877 | ||
| Permissivity of primary cultures of human Kupffer cells for HIV-1. | Q44981195 | ||
| Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? | Q45072473 | ||
| Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? | Q45142113 | ||
| Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection | Q45195944 | ||
| Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus | Q36444289 | ||
| Drug abuse, innate immunity and hepatitis C virus | Q36577777 | ||
| Morphine suppresses intracellular interferon-alpha expression in neuronal cells | Q36874006 | ||
| Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors | Q36984354 | ||
| Effects of opioid tolerance and withdrawal on the immune system | Q37015416 | ||
| Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection | Q37066263 | ||
| Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program | Q37216987 | ||
| Opiate abuse, innate immunity, and bacterial infectious diseases | Q37287395 | ||
| Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects | Q37561259 | ||
| Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus | Q37567921 | ||
| Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects | Q37884772 | ||
| μ-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication | Q38355088 | ||
| gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis | Q38924171 | ||
| Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) colonization and infection in intravenous and inhalational opiate drug abusers | Q38989707 | ||
| Implications of methadone maintenance for theories of narcotic addiction | Q39281451 | ||
| Hepatitis C and Human Immunodeficiency Virus Envelope Proteins Cooperatively Induce Hepatocytic Apoptosis via an Innocent Bystander Mechanism | Q39281648 | ||
| Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment | Q39485422 | ||
| The acquired immunodeficiency syndrome and intravenous drug abuse | Q39557590 | ||
| Hepatitis C and progression of HIV disease | Q39607141 | ||
| HIV increases HCV replication in a TGF-beta1-dependent manner. | Q40004969 | ||
| Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling | Q40010143 | ||
| High incidence of hepatitis C virus reinfection in a cohort of injecting drug users | Q40037737 | ||
| Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein | Q40331093 | ||
| Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells | Q40397346 | ||
| Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. | Q40398346 | ||
| Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells | Q40401232 | ||
| Injection drug use and human immunodeficiency virus infection | Q40405946 | ||
| Human immunodeficiency virus type 1 in illicit-drug solutions used intravenously retains infectivity | Q40437870 | ||
| Outbreak of Acinetobacter baumannii bacteremia related to contaminated morphine used for patient-controlled analgesia | Q40439741 | ||
| Correlates of hepatitis C virus infections among injection drug users. | Q40453200 | ||
| Keeping quiet: microRNAs in HIV-1 latency | Q45230810 | ||
| Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival | Q45334756 | ||
| Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques | Q45413931 | ||
| Pathogenesis of HIV infection: what the virus spares is as important as what it destroys | Q45419109 | ||
| Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection | Q45423509 | ||
| Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy | Q45424761 | ||
| Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China | Q45654072 | ||
| Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group | Q45747079 | ||
| The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users | Q45752296 | ||
| Methadone maintenance and hepatitis C virus infection among injecting drug users | Q45759328 | ||
| Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis | Q45763095 | ||
| Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users | Q45767660 | ||
| Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases | Q45778719 | ||
| Adherence to hepatitis C treatment in recovering heroin users maintained on methadone | Q46126021 | ||
| Morphine-induced transactivation of HIV-1 LTR in human neuroblastoma cells | Q46159012 | ||
| Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12. | Q46507475 | ||
| Splenic macrophages and B cells mediate immunosuppression following abrupt withdrawal from morphine | Q46735687 | ||
| Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit | Q46972445 | ||
| Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model | Q47245276 | ||
| Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells | Q48164028 | ||
| Morphine-induced decreases in in vivo antibody responses | Q48168615 | ||
| Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model | Q48220322 | ||
| Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration. | Q50567817 | ||
| In vitro studies of the effect of methadone on natural killer cell activity. | Q52266427 | ||
| Continued drug use and other cofactors for progression to AIDS among injecting drug users. | Q52272224 | ||
| Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. | Q52274096 | ||
| HIV transmission and the cost-effectiveness of methadone maintenance. | Q52278638 | ||
| Aggravation by morphine and D-aspartic acid of pyelonephritis induced by i. v. inoculation of staphylococcus aureus in rats | Q54391041 | ||
| [Rate of infection by blood-borne viruses in active heroin users in 3 Spanish cities]. | Q55239548 | ||
| Targets for human encoded microRNAs in HIV genes | Q57076044 | ||
| The Effect of Multiple Doses of Peginterferon alfa-2b on the Steady-State Pharmacokinetics of Methadone in Patients With Chronic Hepatitis C Undergoing Methadone Maintenance Therapy | Q59488286 | ||
| Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City | Q64129844 | ||
| Interferon inhibition by narcotic analgesics | Q68653946 | ||
| Suppression of human peripheral blood mononuclear cell function by methadone and morphine | Q69328003 | ||
| Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin | Q72045083 | ||
| Human Kupffer cells infected with HIV-1 in vivo | Q72221656 | ||
| Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids | Q72622006 | ||
| Immunosuppression by morphine is mediated by central pathways | Q72664033 | ||
| Drugs of abuse and infectious diseases | Q72815438 | ||
| Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus | Q73320495 | ||
| [Effect of heroin-containing substances on the infectivity of the human immunodeficiency virus type 1 in vitro] | Q78776587 | ||
| Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy | Q82177447 | ||
| Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model | Q83298306 | ||
| P433 | issue | 4 | |
| P921 | main subject | opioid | Q427523 |
| HIV | Q15787 | ||
| P304 | page(s) | 477-489 | |
| P577 | publication date | 2011-07-14 | |
| P1433 | published in | Journal of Neuroimmune Pharmacology | Q6295645 |
| P1476 | title | Opioids and HIV/HCV infection | |
| P478 | volume | 6 |
| Q59355783 | A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study |
| Q38618111 | Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience |
| Q40421150 | Brief Report: The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation |
| Q92210407 | Decreased Level of Blood MicroRNA-133b in Men with Opioid Use Disorder on Methadone Maintenance Therapy |
| Q40179209 | Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs |
| Q90741371 | Dorsal hippocampal neural immune signaling regulates heroin-conditioned immunomodulation but not heroin-conditioned place preference |
| Q85091957 | Drugs of abuse effects on immunity and microbial pathogenesis |
| Q61807560 | Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study |
| Q60907504 | Evaluation of Immunomodulatory and Hematologic Cell Outcome in Heroin/Opioid Addicts |
| Q36974887 | Factors associated with mortality of HIV-positive clients receiving methadone maintenance treatment in China |
| Q90636085 | GRK5 Is Associated with the Regulation of Methadone Dosage in Heroin Dependence |
| Q28483942 | HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China |
| Q35531310 | HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses |
| Q28534782 | Hepatitis C virus infection influences the S-methadone metabolite plasma concentration |
| Q36245718 | Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages |
| Q47105347 | Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant |
| Q55425578 | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
| Q34620651 | Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder |
| Q40561436 | Methadone enhances human influenza A virus replication |
| Q57153198 | Morphine Potentiates Dysbiotic Microbial and Metabolic Shifts in Acute SIV Infection |
| Q98564963 | Neuronal regulation of immunity: why, how and where? |
| Q37003023 | Substance abuse, HIV-1 and hepatitis |
| Q40562116 | T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. |
| Q26782833 | Vitamin D receptor and epigenetics in HIV infection and drug abuse |
Search more.